Introduction
The Ras signalling pathway is involved in cell growth and differentiation. Mutations in the Ras proto-oncogene have been described in a large variety of human malignancies [1] .
These mutations result in a constitutively active Ras protein, which is one of the most common Ras dysregulations in cancers [1, 2] . Three different Ras genes encoding the H-Ras, K-Ras and N-Ras 21 kDa proteins were discovered 30 years ago [1, 3] . The activated Ras proteins physically associate with and activate Raf-1, a serine/threonine kinase which triggers a kinase cascade that results in the activation of the extracellular signal-regulated protein kinases (ERKs of the MAPK family). Ras acts as a functional hub by activating multiple downstream pathways that participate in cell growth and differentiation. The activity of Ras is regulated by two sets of proteins: guanine-nucleotide exchange factors (GEFs) and GTPaseactivating proteins (GAPs). GEFs stimulate the release of the Ras bound GDP which then allows GTP to bind and activate Ras. Conversely, GAPs stimulate Ras GTPase activity and lead to the basal GDP-bound state.
Several pathways, which lead to the active Ras state, have been described in mammalian cells. The best-characterized pathway employs the activation of tyrosine kinase receptors to elicit binding of various proteins to the phosphorylated receptor, most notably the growth factor receptor bound 2 (Grb2) protein bound to the guanine nucleotide exchange factor SOS1. The complex is targeted to the plasma membrane, allowing the GEF function of SOS1 to activate Ras by GDP/GTP exchange [4] [5] [6] . SOS1 can activate other GTP-binding proteins [4] and other effectors also control Ras activity. The most extensively characterized non-physiological conditions under which increased SOS activitiy has been observed result from gain of function mutations. For example, SOS1 mutations have been described in the Noonan syndrome, a developmental disorder that is characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies [7, 8] . These gain of function mutations, which lead to the activation of Ras and were the first examples of activating GEF mutations associated with human disease. Surprisingly, the implications of increased expression of SOS proteins have not been addressed and little is known about the regulation of the gene promoter.
Dioxin is a member of the PolyChlorinated dibenzo Dioxins (PCDD) family which is a class of highly persistent environmental contaminants. 2, 3, 7, (TCDD), the most extensively characterized dioxin, has been classified in 1997 as a "human carcinogen" by the International Agency for Research on Cancer (IARC) [9] . This pollutant is the ligand with the greatest affinity for the Aryl Hydrocarbon Receptor (AhR). TCDD via the 4 AhR, induces various toxicities including chloracne, wasting syndrome, teratogenicity, immunotoxicity, neurotoxicity, tumor promotion and carcinogenesis [10] . The AhR is a cytosolic, ligand-activated transcription factor which, upon activation, translocates to the nucleus where it forms a heterodimer complex with AhR Nuclear Translocator (ARNT). This complex binds to specific Xenobiotic Responsive Elements (XRE) which are characterized by a 5'-GCGTG-3' consensus core and induces specific target genes which include xenobiotic metabolizing enzymes (XME) such as the cytochrome P450 (CYP) 1 family [11] . In addition to detoxification functions, the activation of this receptor has been shown to elicit diverse cellular effects including cell proliferation [12, 13] . These cellular alterations might mediate part of the long-term toxicity of the AhR ligands in animals and humans [14] . Indeed, AhRnull mice display several defects of development and proliferation including thymus and liver hypotrophy [15] . Numerous studies using AhR defective cells or AhR invalidating strategies have clearly established a role for this receptor in cell cycle regulation and proliferation [16] .
The dysregulation of these cellular pathways may disrupt normal fetal development and favor cancer progression. The AhR gene targets that are involved in the proliferative effects of this receptor are not completely identified. To this end, we have examined large-scale toxicogenomic analyses of dioxin effects and focused on regulatory proteins that control cellular growth, in particular, the main mediator of Ras activation, SOS1.
In the present work, we investigated, for the first time, the regulation of the previously uncharacterized SOS1 gene promoter by the AhR and its ligands in the human hepatocarcinoma cell line, HepG2. We show that several environmental pollutants (AhR ligands) induce SOS1 gene expression via increased transcription. Moreover, considering the critical role of SOS1 in controlling Ras activity, we also demonstrate that induction of SOS1 by AhR ligands leads to a predominant Ras-GTP state, to MAPK activation and to cell growth. The results point towards SOS1 gene induction as being a critical step for the carcinogenic effects mediated by dioxins.
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Materials and methods

Cell Culture.
Human hepatocarcinoma HepG2 cells were cultured in Dulbecco's minimal essential medium (DMEM, Invitrogen, Cergy-Pontoise, France) supplemented with nonessential amino acids and containing 10% fetal bovine serum, 200 U/mL penicillin, 50 µg/mL streptomycin (Invitrogen) and 0.5 U/mL amphotericin B (Bristol-Myers Squibb Co., Stamford, CT) at 37°C in a humidified atmosphere of 5% CO 2 in air. The day before with the addition of various concentrations of TCDD, cells were cultured in DMEM without phenol red and supplemented with 3% charcoal-treated (desteroidized) calf serum. Cells were maintained in this medium during all the treatments except for the proliferation studies.
TCDD was purchased from LCG Promochem (Molsheim, France). Benzo(a)pyrene, and quercetin were purchased from Sigma-Aldrich (St Louis, United States).
RNA extraction, reverse transcription and quantitative RT-PCR. Total RNAs
were extracted using the RNeasy mini kit (Qiagen, Les Ulis France) and reverse transcription was performed with each RNA sample using the cDNA High-Capacity Archive kit (Applied Biosystems, Courtaboeuf, France) as previously described [17] . Specific oligonucleotides were designed using the OLIGO Explorer software (Molecular Biology Insights, Inc., Cascade, CO). Gene specific primers used for the real time PCR were: SOS1: forward 5'-TGAGAGGCAACAGAAAGAGC-3' and reverse 5'-GAGAAGGGAAATGAAATGGG-3'; M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   7 The reverse transcription product was separated on a denaturing acrylamide gel. After migration, radioactive bands were visualized with a phosphorimager (STORM 580). The cells were then treated or not with 25 nM TCDD as described above. The supernatant was then harvested at0h, 6h, 24h and 48h after TCDD treatment. A luciferase assay (Gaussia)
AhR
was performed with a New England Biolabs kit (E3300L) and a luminometer (Lumat LB9507, Berthold, Thoiry, France).
Chromatin Immunoprecipitation. HepG2 cells were seeded into 150-mm-diameter
dishes (approximately 20x10 6 cells per dish) 48h before being processed for ChIP as previously described [17] . Treatment with TCDD (25nM) was performed, as described above, The recovered proteins were separated by SDS-PAGE (see above) and western blots (Ras antibody) were performed. Moreover, we used GTP gamma-S as a positive control and GDP as a negative control (Upstate). 
Statistical analysis.
The data result from at least three independent experiments.
The results were expressed as the mean ± standard error. Differences between groups were analyzed by U Mann-Whitney's test (nonparametric comparison of 2 independent series) or H Kruskal-Wallis's test (nonparametric comparison of k independent series) followed by a 1-9 factor ANOVA test (parametric comparison of k independent series). A p-value < 0.05 was considered as statistically significant.
Results
TCDD is known to promote cellular proliferation and cell cycle progression in different cellular models. Since several toxicogenomic large-scale studies, including our own, were performed in the human hepatocarcinoma HepG2 cell line and since this cell line exhibits high levels of AhR expression, we used the HepG2 cells for our gene regulation studies. As will be shown later in this article, TCDD elicited a 20% increase in the number of cells during the exponential phase of growth. Thus, the HepG2 cells constitute an appropriate model to investigate the molecular mechanisms of TCDD-elicited cellular proliferation.
Effect of dioxin treatment on SOS1 mRNA and protein levels in HepG2 cells.
In a large-scale gene expression study, SOS1 mRNA was found to be induced by TCDD [18] . BaP, significantly increased SOS1 mRNA; although an increase in SOS1 mRNA was also observed after treatment of cells with 25 µM Quercetin, this increase was not significant. We then knocked down AhR expression using specific siRNA (Fig 2B) , which decreased AhR mRNA by approximately 60-70% (Fig 2B) . AhR levels remain knock-downed throughout the time course of the experiment (Supplementary figure 3) . Figure 2C and 2D show that AhR siRNA treatment elicited a statistically significant 50% decrease in both SOS1 mRNA and protein induction by TCDD. In this experiment, we did not expect to completely knock-down
AhR levels but we aimed to correlate the relationship between both AhR and SOS1 levels; we observed such a correlation (AhR by the time of treatment, 0h, 50% decreased levels and SOS1 at the end of the experiment, 50% decrease) and also a 60% decrease in CYP1A1 induction which is classically measured to prove AhR activation (data not shown). These experiments demonstrate that the activated AhR regulates SOS1 mRNA and protein levels. Several experiments were carried out in order to determine whether the SOS1 gene promoter is a direct target of the AhR, including luciferase reporter gene assays ( Figure 4A and 4B) and Chromatin ImmunoPrecipitation (ChIP) assays using a specific AhR antibody A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 ( Figure 4C ). We subcloned the (-2200/+37) fragment of the SOS1 gene promoter (which includes the two putative XREs) upstream of the Gaussia luciferase reporter gene. The activity of this gene product can be readily monitored in the medium. Following transfection with this recombinant reporter gene plasmid, HepG2 cells were treated with TCDD and the medium was recovered at different time points for luciferase assay ( Figure 4A) . A significant increase in luciferase activity can be observed 24 and 48 hours following TCDD treatment.
These experiments confirm that the (-2200/+37) SOS1 gene fragment exhibits promoter activity as compared to the empty vector ( Figure 4B ), and suggest that this gene promoter fragment mediates part of the inducing effect of TCDD. Similar experiments were performed in control siRNA and AhR-siRNA treated cells (Fig 4B) . We observed a similar 2-to 3-fold increase in the activity of the SOS1 gene promoter in siControl-transfected cells upon TCDD treatment. However, basal and induced SOS1 promoter activities were significantly reduced in AhR-depleted cells suggesting a contribution of this receptor to SOS1 gene promoter activation.
Finally, we performed a Chromatin Immuno Precipitation (ChIP) experiment using a SOS1 promoter fragment (-984/-801) to confirm the direct binding of AhR to the endogenous SOS1 gene promoter ( Figure 4C ). AhR antibody and real-time PCR were used to provide a quantitative measurement of receptor binding. Cells were treated for 15 and 45 minutes with TCDD. Several controls were used for the experiments (inputs, mock antibody). We observed a time-dependent, specific and potent increase of AhR binding to the SOS1 gene promoter.
Altogether, these experiments clearly show that the TCDD-mediated transcriptional regulation of the SOS1 gene is related to the rapid direct binding of the AhR to the promoter.
TCDD stimulates Ras activity and ERK1/2 phosphorylation through induction of SOS1.
Since the Guanine nucleotide Exchange Factor SOS1 regulates the Ras-MAPK pathway, we hypothesized that increased amounts of SOS1 could lead to the activation of this pathway. Thus, we monitored Ras activity (the active GTP-bound form) and ERK phosphorylation following TCDD treatment of HepG2 cells. To monitor Ras activity, we performed affinity pull-down experiments. Beads grafted with the domain of Raf, which specifically interacts, with the GTP-bound form of Ras were mixed with different cellular extracts. The bound fraction was then eluted and analyzed with a Ras antibody. Figure 5A shows that the active form of Ras was increased following TCDD treatment. In parallel, the phosphorylated fraction of ERK was also increased by TCDD treatment (fig 5B) . To assess the implication of SOS1 in these processes, we down-regulated SOS1 expression using a (Fig 6A) using two specific siRNAs, the effect of TCDD was completely abolished. A partial decrease in basal cellular proliferation was also noted, which is not surprising given the implication of the SOS1-Ras-ERK pathway in cellular proliferation. In addition, AhR-specific siRNAs also prevented the TCDD effects (Fig 6B) . We conclude that SOS1 induction plays a critical role in the TCDDelicited increase in cellular proliferation.
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Discussion
AhR activation by polyaromatic and polyhalogenated hydrocarbons has traditionally been associated with induced expression of phase I and phase II xenobiotic metabolizing enzymes, which promote the clearance of pollutants and drugs from metazoan organisms [20] .
However, recent toxicogenomic studies, as well as knock-out studies in mice, have unveiled new AhR target genes [13, [21] [22] [23] and suggested novel functions for this receptor including the regulation of cell proliferation and migration. Several large-scale studies in HepG2 cells [21, 22, 24] indicated that the SOS1 gene could be a target of TCDD. SOS1, a Guanine Exchange Factor, is essential for the activation of the Ras and Rac signaling pathways, which lead to the regulation of some of the most important cellular functions including cell division, differentiation and migration [4] . Despite these critical roles, neither the regulation of SOS1 expression nor the characterization of its gene promoter has been carried out previously. We recently observed that AhR ligands increase HepG2 cell proliferation and hypothesized that increased SOS1 expression might be involved in this biological effect. We first validated our transcriptomic experiments and showed that the AhR and its ligands positively regulate SOS1 gene expression. Then, we characterized and subcloned, for the first time to our knowledge, the human SOS1 gene promoter. We showed that TCDD and other AhR ligands regulate, via transcriptional mechanisms their activities upon AhR activation followed by direct promoter binding of AhR to XRE sites. Interestingly, the level of induction of SOS1 elicited by each ligand is different. This is in line with one of our former studies showing that the transcriptional response of the AhR depends on the nature of its ligand ( [25] ) and, more generally, with the SAhRM concept [26] . Finally, we focused on the implications of the regulation of SOS1 expression by environmental pollutants. Using a siRNA strategy, we demonstrated that increased SOS1 expression is directly linked to Ras and ERK activation, which promotes cell division. This study demonstrates that the activation of the Ras-ERK pathway could be achieved by increasing the amount of the SOS1 protein. These results suggest that, under our cell culture conditions, the amount of SOS1 protein is limiting.
The activation of the Ras ERK pathway has been studied extensively in the past and several mechanisms have been reported and characterized [19] . Receptor activation followed by SOS1 recruitment is a classical mechanism under physiological and certain pathological conditions and is one paradigm for cellular signaling [6] . In cancer cells, considerable research has been devoted to the upregulation of this pathway through activating Ras A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 mutations. Similarly, the function of SOS1 has been considerably investigated [27] [28] [29] .
Recent studies also have correlated SOS1 activating mutations to several diseases of development including Noonan syndrome, a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal abnormalities [7, 8, 30] as well as hereditary gingival fibromatosis type 1, a benign overgrowth condition of the gingiva [31] . Despite considerable attention to these gains of function mutations, SOS1 gene regulation has remained poorly characterized [32, 33] . We speculate that the findings reported here on the upregulation of SOS1 gene expression by environmental pollutants might constitute one mechanism, which accounts for TCDD and other AhR ligand-mediated carcinogenesis. We expect this effect to be particularly relevant in cancerous cells, which do not exhibit Ras mutations. Indeed, continuous upregulation of SOS1 in these cells may mimic
Ras mutational activation and lead to the permanent stimulation of the downstream signaling pathway, which controls cellular proliferation. Thus, our data imply that increased SOS1 expression may constitute an alternative to the activating mutations of Ras and that it should be relevant to explore and characterize alterations of the expression of this gene in cancer cells [34] [35] [36] . Furthermore, it is unclear at this stage whether these two mechanisms can be additive or not. An important question, in this respect, is whether gene induction-mediated chronic activation of the SOS1/Ras pathway can be achieved readily in humans. Because of the high contamination levels and widespread distribution of AhR ligands in our environment, chronic exposure to such pollutants is very common, especially in industrialized countries. In addition, long term effects could also be triggered by acute high level exposure to these toxins. Indeed, pollutants such as dioxins tend to resist metabolism and accumulate in human and animal adipose tissue, leading to a permanent internal exposure [37] .
Genetic and developmental studies in flies and mice have suggested different and unexpected connections between the AhR and the small G proteins network. A recent study by CarvajalGonzalez JM et al using AhR KO mice models, has unveiled a link between the receptor and the Vav3, a guanosine diphosphate/guanosine triphosphate exchange factor for Rho/Rac
GTPases [38] . Moreover, Son of Sevenless (SOS) has been shown to be a major player in the development of Drosophila eye ommatidia. SOS mutations change ommatidia organization and the color perception of the fly [39, 40] . Spineless, the Drosophila AhR ortholog, is involved in the ommatidal mosaic formation as well as SOS1 [41] . Thus, these two genes converge in the control of eye development. [42, 43] . Thus, it is likely that several of those AhR functions including SOS1 regulation, have been conserved through evolution and the present study as well as several others suggest that one mechanism of pollutants toxicity would be to disrupt such basic developmental functions of this receptor. Actin was used as a loading control for western blots. **, p < 0.01 as compared to non-treated controls (n > 3). Actin was used as a loading control for western blots (n=3). Input refers to non-precipitated samples and is used to ensure proper "loading" controls before precipitation. The mock antibody is used to measure unspecific precipitations. Fold induction refers to relative levels calculated using non-treated (NT) conditions as reference.
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